Trinity Biotech annual operating margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Trinity Biotech's operating margin was −34.38% for fiscal 2024.
View full Trinity Biotech company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −34.38% | +13.20 pp |
| 2023 | 2023-12-31 | −47.59% | −16.64 pp |
| 2022 | 2022-12-31 | −30.95% | −35.80 pp |
| 2021 | 2021-12-31 | 4.85% | +4.77 pp |
| 2020 | 2020-12-31 | 0.08% | +26.74 pp |
| 2019 | 2019-12-31 | −26.66% | −5.82 pp |
| 2018 | 2018-12-31 | −20.85% | +17.15 pp |
| 2017 | 2017-12-31 | −37.99% | +2.01 pp |
| 2016 | 2016-12-31 | −40.00% | −53.48 pp |
| 2015 | 2015-12-31 | 13.48% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2018 | 2018-06-30 | 6.90% | — |
| Q2 2017 | 2017-06-30 | 7.20% | — |
Over the last five reported fiscal years, Trinity Biotech's operating margin decreased from −26.66% to −34.38%, a change of −7.72 percentage points. The latest reported quarter, Q2 2018, shows 6.90%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trinity Biotech filings at SEC.gov ↗